Other laboratory parameters such as leucocytes registered a positive trend in both groups with a mean difference of 3.73 ± 7.214 10 9 /L in the treated group and 5.17 ± 7.66 10 9 /L in controls ( p = 0.26 and p = 0.52, respectively).
TSAT also increased in the treated by a mean of 16.67 ± 15.25% ( p = 0.044) but followed a decreasing trend in controls by a mean difference of −6.333 ± 6.122% ( p = 0.33).
IL-6 followed an increasing trend in both the treatment and control groups, with a mean difference of 674.6 ± 838.9 pg/mL in the treated and 341.3 ± 554.5 pg/mL in controls; however, this did not reach statistical significance ( p = 0.106 in treated and p = 0.552 in controls).